RNA Nanobiotics Due Diligence Call

RNA Nanobiotics presented at WAA's 17-Oct Life Sciences Pitch Event.

A due diligence call is on Thursday, 07-Nov-2024 at 5pm PT // 8pm ET.

Please submit due diligence questions for RNA Nanobiotics: RNA NanoBiotics_DD_Pitch Follow-up Questions_17-Oct-2024

Joining information will be sent upon registration.

  RNA Nanobiotics has RNA Nanotechnology for Targeted Delivery of RNAi, Radioisotopes, and Chemotherapeutics for Oncology

⭐Sourced by James Carroll

Deal Lead: Andrew Davies ([email protected]) // @Andrew Davies on Slack

• PROBLEM: Cancer is the most deadly disease in the developed world as one in three people develop cancer in their lifetime. The cure for cancer is like the Holy Grail since most of the existing treatments are not effective enough to provide full protection from the disease.
• SOLUTION: RNA Nanobiotics was established to spearhead the translation of RNA nanotechnology into an innovative delivery system able to improve the therapeutic outcome of patients with cancer. Our proprietary RNA Nanotechnology Platform allows for Targeted Delivery of RNAi, Radioisotopes and Chemotherapeutics for safe and effective cancer treatments.
• WAA Member Interest: ≥ $70K
• RNA NonoBiotics Pitch Deck
• Of Note:
  • SAFE
  • $12MM pre money valuation
  • 20% discount upon conversion
• #1-rna-nanobiotics on Slack